RU2017137960A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017137960A3 RU2017137960A3 RU2017137960A RU2017137960A RU2017137960A3 RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3 RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/001316 WO2016156912A1 (en) | 2015-04-01 | 2015-04-01 | Use of thia oxo compounds for lowering apo c3 |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017137960A3 true RU2017137960A3 (ru) | 2019-05-06 |
RU2017137960A RU2017137960A (ru) | 2019-05-06 |
RU2705991C2 RU2705991C2 (ru) | 2019-11-13 |
Family
ID=53879725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017137960A RU2705991C2 (ru) | 2015-04-01 | 2015-04-01 | Применение тиаоксосоединений для уменьшения содержания аро с3 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20180110747A1 (ru) |
JP (1) | JP2018510206A (ru) |
KR (1) | KR20180010181A (ru) |
AU (1) | AU2015389862B2 (ru) |
MX (1) | MX2017012641A (ru) |
RU (1) | RU2705991C2 (ru) |
WO (1) | WO2016156912A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016173923A1 (en) | 2015-04-28 | 2016-11-03 | Pronova Biopharma Norge As | Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis |
IL275002B2 (en) | 2017-12-06 | 2024-04-01 | Basf As | Fatty acid antecedents for the treatment of nonalcoholic fatty liver disease |
CA3101041A1 (en) | 2018-05-23 | 2019-11-28 | Northsea Therapeutics B.V. | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease |
JP2023554524A (ja) | 2020-12-22 | 2023-12-27 | ノースシー セラピューティクス ベスローテン フェンノートシャップ | 非アルコール性脂肪性肝炎の治療のための酸素含有構造強化脂肪酸を含む組合せ療法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2726765T3 (es) * | 2009-05-08 | 2019-10-09 | Basf As | Acidos grasos poliinsaturados para el tratamiento de enfermedades relacionadas con el campo de enfermedades cardiovasculares, metabólicas e inflamatorias |
BR112013010890B1 (pt) * | 2010-11-05 | 2020-03-10 | Basf As | Uso de um composto para a fabricação de um medicamento para tratamento ou prevenção de uma condição de apo b elevado |
RU2645075C2 (ru) * | 2012-05-07 | 2018-02-15 | Омтера Фармасьютикалс, Инк. | Композиции статинов и омега-3 жирных кислот |
EP2961384B1 (en) * | 2013-02-28 | 2019-08-28 | Basf As | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same |
-
2015
- 2015-04-01 AU AU2015389862A patent/AU2015389862B2/en active Active
- 2015-04-01 WO PCT/IB2015/001316 patent/WO2016156912A1/en active Application Filing
- 2015-04-01 JP JP2017552093A patent/JP2018510206A/ja active Pending
- 2015-04-01 RU RU2017137960A patent/RU2705991C2/ru active
- 2015-04-01 KR KR1020177031665A patent/KR20180010181A/ko not_active IP Right Cessation
- 2015-04-01 US US15/562,554 patent/US20180110747A1/en not_active Abandoned
- 2015-04-01 MX MX2017012641A patent/MX2017012641A/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180010181A (ko) | 2018-01-30 |
WO2016156912A1 (en) | 2016-10-06 |
MX2017012641A (es) | 2018-06-06 |
AU2015389862A1 (en) | 2017-11-23 |
US20180110747A1 (en) | 2018-04-26 |
RU2705991C2 (ru) | 2019-11-13 |
AU2015389862B2 (en) | 2021-04-15 |
JP2018510206A (ja) | 2018-04-12 |
RU2017137960A (ru) | 2019-05-06 |